XTalks

AUGUST 2, 2023

Most of the company’s revenue comes from the manufacture and sale of biopharmaceutical products. billion in pharmaceutical sales from 2021. In contrast, several drugs experienced sale declines, such as Remicade (infliximab), an old immunology medication that continues to decline due to the rise of biosimilars since 2016.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

The Pharma Data

DECEMBER 28, 2020

Amphastar’s newly approved synthetic peptide product was determined by the FDA to be bioequivalent and therapeutically equivalent to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar, which has a recombinant DNA (rDNA)-origin. Additionally, the Company sells insulin API products. ” According to IQVIA, the U.S.

Bioequivalency 52

Bioequivalency Production Sales Marketing 52

The Pharma Data

AUGUST 3, 2021

The trial compared tirzepatide to insulin glargine in adults with type 2 diabetes and increased cardiovascular risk. million of revenue associated with the sale of its rights to Cialis ® in China. million of revenue from sales of COVID-19 antibodies. During the second quarter of 2021, the company recognized $170.0

Antibody 52

Antibody Sales Production Development 52

The Pharma Data

MAY 13, 2021

Stimulates DNA and RNA synthesis. Jonathan was in his late 40s and came into my pharmacy to pick up his insulin for his diabetes, when he told me about his father. CLICKBANK® is a registered trademark of Click Sales Inc., Increases your energy levels by increasing ATP production. Activates and speeds up the lymphatic system.

Pharmacy 52

Pharmacy Production Doctors Doctor 52